Non-classical drug metabolism enzymes: The curious case of phenylalanine 4-monooxygenase

Letters in Drug Design and Discovery

Volumn 3, Issue 6, 2006, Pages 405-412

  Steventon, G B ^a,c   Mitchell, S C ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Centre for Research in Rehabilitation School of Health Science and Social Care   (United Kingdom)

Author keywords

Genetic polymorphism; Hormonal regulation; Phenylalanine 4 monooxygenase; S carboxymethyl L cysteine; S oxidation

Indexed keywords

ALDEHYDE OXIDASE; CARBOCISTEINE; DOPAMINE BETA MONOOXYGENASE; DRUG METABOLIZING ENZYME; LIPOXYGENASE; MUCOLYTIC AGENT; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; PROSTAGLANDIN SYNTHASE; S METHYLCYSTEINE; XANTHINE OXIDASE; XENOBIOTIC AGENT;

ARTICLE; BIOTRANSFORMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG METABOLISM; GENETIC POLYMORPHISM; HUMAN; OTITIS MEDIA; OXIDATION; PHENYLKETONURIA; PRIORITY JOURNAL;

EID: 33746663505     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018006777805512     Document Type: Article

References (49)

1. Ure, A. London Medical Gazette, 1841, 1, 735.
2. Mitchell, S.C.; Carmichael, P.L.; Waring, R.H. Biologist, 2004, 51 212.
3. Bachmann, C.; Bickel M.H. Drug Metab. Rev., 1985-86, 16, 185.
4. Quick, A.J. J.Biol. Chem.,1928, 77, 581.
5. Sherwin, C.P. Physiol. Rev., 1922, 2, 238.
6. Guengerich, F.P.; Wu, Z.L.; Bartleson, C.J. Biochem. Biophys. Res. Commun., 2005, 338, 465.
7. Gervasini, G.; Carrillo, J.A.; Benitez, J. Clin. Pharmacokinet., 2004, 43, 693.
8. Cashman, J.R. Drug Metab. Rev., 2002, 34, 513.
9. Cashman, J.R. Pharmacogenomics, 2002, 3, 325.
10. Elfarra, A.A. Chem. Biol. Interact., 1995, 96, 47.
11. Krueger, S.K.; Williams, D.E.; Yueh, M.F.; Martin, S.R.; Hines, R.N.; Raucy, J.L.; Dolphin, C.T.; Shephard, E.A.; Phillips, I.R. Drug Metab. Rev., 2002, 34, 523.
12. Birkett, D.J.; Miner, J.O.; Day, R.O. Brit. J. Clin. Pharmacol., 1991, 32, 238.
13. Van Scoik, K.G.; Johnson, C.A.; Porter, W.R. Drug Metab. Rev., 1985, 16, 157.
14. Beedham, C.; Critchley, D.J.; Rance, D.J. Arch. Biochem. Biophys., 1995, 319, 481.
15. Kaye, B.; Rance, D.J.; Waring, L. Xenobiotica, 1985, 15, 237.
16. Egan, R.W.; Gale, P.H.; Kuehl, F.A., J. Biol. Chem., 1979, 254, 3295.
17. Egan, R.W.; Gale, P.H.; Vanden Heuvel, W.J.; Baptista, E.M.; Kuehl, F.A. J. Biol. Chem., 1980, 25, 323.
18. Lasker, J.M.; Sirvarajah, K.; Mason, R.; Kalyanaraman, B.; Abou-Donia, M.H.; Eling, T.E. J. Biol. Chem., 1981, 256, 7764.
19. Portoghese P.S.; Svanbork, K.; Samuelsson, B. Biochem. Biophys. Res. Commun., 1975, 63, 748.
20. Hughes, M.F.; Mason, R.; Eling, T.E. Mol. Pharmacol., 1988, 34, 186.
21. Samuelsson, B.; Goldyne, M.; Granstrom, E.; Hamberg, N.; Hammarström, S.; Malmsten, C. Ann. Rev. Biochem., 1978, 47, 997.
22. Hover, C.G.; Kulkarni, A.P. Placenta, 2000, 21, 646.
23. Hu, J.; Sajan, M.; Kulkarni, A.P. Inter. J. Toxicol., 1999, 18, 251.
24. May, S.W.; Phillips, R.S.; Mueller, P.W.; Herman, H.H.. J. Biol. Chem., 1981, 256, 8470.
25. May, S.W.; Phillips, R.S. J. Am. Chem. Soc., 1980, 102, 5981.
26. Rochat, B.; Kosel, M.; Boss, G.; Testa, B.; Gollet, M.; Baumann, P. Biochem. Pharmacol., 1998, 56, 15.
27. Dixon, C.M.; Park, G.R.; Tarbit, M.H. Biochem. Pharmacol., 1994, 47, 1253.
28. Steventon, G.B. Drug Metab. Dispo., 1999, 27, 1092.
29. Mitchell, S.C.;Waring, R.H.; Haley, C.S.; Idle, J.R.; Smith, R.L. Br. J. Clin. Pharmacol., 1984, 18, 507.
30. Mitchell, S.C.; Waring R.H. Pharmacol. Therap., 1989, 43, 237.
31. Waring, R.H.; Mitchell, S.C.; O'Gorman, J.; Fraser, M. Biochem. Pharmacol., 1986, 35, 2999.
32. Khan, S.; Mitchell, S.C.; Steventon, G.B. J. Pharm. Pharmacol., 2004, 56, 993.
33. Goreish, A.H.; Bednar, S.; Jones, H.; Mitchell, S.C.; Steventon, G.B. Drug Metab. Drug Inter., 2004, 20, 159.
34. Boonyapit, B., Panagopoulos, P., Jones, H., Mitchell, S.C., Forbes, B., Steventon, G.B. Drug Metab. Drug Inter., 2005, 21, 1.
35. McGill University, Canada, PAHdb Phenylalanine Hydroxylase Locus Knowledgebase. http://www.pahdb.mcgill.ca.
36. Hufton, S.E.; Jennings, I.G.; Cotton, R.G. Biochem. J., 1995, 311, 353.
37. Thorolfsson, M.; Teigen, K.; Martinez, A. Biochemistry, 2003, 42, 3419.
38. Fitzpatrick, P.F. Annu. Rev. Biochem., 1999, 68, 355.
39. Kaufman, S.; Mason, K. J. Biol. Chem., 1982, 257, 14667.
40. Boonyapiwat, B.; Forbes, B.; Steventon, G. B. Anal. Biochem., 2004, 335, 91.
41. Cooper, C.E.; Patel R.P.;Brookes, P.S.; Darley-Usmar, V. M. T. I. B. S., 2002, 27, 489.
42. Jacob, C.; Lancaster, J.R.; Giles, G.I. Biochem. Soc. Trans., 2004, 32, 1015.
43. Zou, C.-C.; Banerjee, R. J. Biol. Chem., 2003, 278, 16802.
44. Haley, C.S.; Waring, R.H.; Mitchell, S.C.; Shah, R.R.; Idle, J.R.; Smith, R.L. Xenobiotica, 1985, 15, 445.
45. Mitchell, S.C.; Waring, R.H.; Land, D.; Thorpe, W.V. Experientia, 1987, 43, 382.
46. Ayesh, R.; Mitchell, S.C.; Waring, R.H.; Smith, R.L. Br. J. Clin. Pharmacol., 1988, 25, 644P.
47. Waston, R.G.P.; Olomu, A.; Clements, D.; Waring, R.H.; Mitchell, S.C.; Elias, E. J. Hepatol., 1988, 7, 72.
48. Kupfer, A; Idle, J.R. Lancet, 1990, 335, 1107.
49. Steventon, G.B.; Sturman, S.; Waring, R.H.; Williams, A.C. Drug Metab. Drug. Inter., 2001, 18, 79.